c-Myc, EGFR signaling, and the activated PI3K pathway all promote breast cancer aerobic glycolysis, suggesting the roles of these pathways in the metabolic type of these breast cancer subtypes [22,23,24]. This evidence concerns the gene EGFR and breast carcinoma.